Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01080183 · ClinicalTrials.gov registry record · NA

Functional Assessment Screening Tablets - Patient Reported Measures

A NA study, sponsored by University of Pittsburgh.

Completed
Registry status
NA
Development phase
150
Enrollment target

NCT01080183: Completed NA study, sponsored by University of Pittsburgh.

NCT01080183 is a NA study that has completed, run by University of Pittsburgh. The registered enrollment target is 150 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01080183, a NA study, has completed, sponsored by University of Pittsburgh.

COMPLETED
Registry status
NA
Development phase
150 participants
Enrollment target

Study Summary

The team's ultimate goal is to improve health care quality and effectiveness and support patient-centered care. In this project, we, the investigators, will test whether providing patients with guideline based-recommendations regarding tobacco use, physical activity and mental and physical health-related quality of life (patient reported measures: PRMs) using health information technology increases doctor-patient discussions regarding these topics and results in improvements in PRMs. We will randomize physicians in a single general internal medicine practice. Patients seeing intervention physicians will receive guideline-based recommendations regarding PRMs, those seeing control physicians will not. We will compare differences in doctor-patient discussions regarding PRMs between the intervention and control groups. The successful completion of this project will provide evidence the effectiveness of involving patients in their care through the use guideline-based feedback.

Primary Outcome

the doctor patient and encounter will be queried for communication regarding the patient reported measures

Interventions

  • OTHER Patient feedback form

Trial Details

FieldValue
Enrollment Target 150 participants
Start Date 2010-03
Est. Completion 2010-10
Phase NA
University of Pittsburgh

1,238 total trials

What the finished NCT01080183 record still lists

NCT01080183 is an interventional study that assigns participants to a tested intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 1 intervention - of which Patient feedback form is the first listed.

NCT01080183 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01080183 about?

NCT01080183 is a clinical study titled "Functional Assessment Screening Tablets - Patient Reported Measures". The team's ultimate goal is to improve health care quality and effectiveness and support patient-centered care. In this project, we, the investigators, will test whether providing patients with guideline based-recommendations regarding tobacco use, physical activity and mental and physical health-re...

What is the current status of trial NCT01080183?

This trial is currently completed. It is a NA study. The enrollment target is 150 participants. The study started on 2010-03. Estimated completion is 2010-10.

What interventions are being tested in trial NCT01080183?

The interventions under investigation include: Patient feedback form (OTHER).

Who is sponsoring clinical trial NCT01080183?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01080183's enrollment target sits among peer trials

150 661st of 2000 higher than 1,299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00412594 · 150 participants · Phase 2

    Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia

  • NCT01484730 · 150 participants

    A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion

  • NCT01985919 · 150 participants

    Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples

  • NCT02016248 · 150 participants · NA

    SBRT Boost for Unfavorable Prostate Cancer'

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01080183, the US trial registry maintained by the National Library of Medicine. NCT01080183 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.